Showing results (311-320 of 321) with videos related to

Sort By:
Pageof 33
Journal of Medical Virology|January 18, 2024
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19Alexi Vasbinder, Kishan Padalia, Ian Pizzo, et al.
BMJ Open|November 11, 2022
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trialChristian Morath, Anita Schmitt, Michael Schmitt, et al.
Frontiers in Immunology|July 24, 2023
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantationMatthias Schaier, Christian Morath, Lei Wang, et al.
Nature Metabolism|March 29, 2022
Molecular consequences of SARS-CoV-2 liver tropismNicola Wanner, Geoffroy Andrieux, Pau Badia-I-Mompel, et al.
JAMA Internal Medicine|July 16, 2020
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the USShruti Gupta, Salim S Hayek, Wei Wang, et al.
Kidney International|May 16, 2020
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus ConferenceAndrew S Levey, Kai-Uwe Eckardt, Nijsje M Dorman, et al.
JAMA Internal Medicine|October 20, 2020
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19Shruti Gupta, Wei Wang, Salim S Hayek, et al.
The Journal of Clinical Investigation|October 4, 2022
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosisGeorge Hindy, Daniel J Tyrrell, Alexi Vasbinder, et al.
The Journal of Clinical Investigation|March 7, 2017
CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosusMohd Hafeez Faridi, Samia Q Khan, Wenpu Zhao, et al.
The Journal of Clinical Investigation|May 5, 2011
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafnessSaskia F Heeringa, Gil Chernin, Moumita Chaki, et al.
Pageof 33